Comparison of usefulness of dipyridamole stress myocardial contrast echocardiography to technetium-99m sestamibi single-photon emission computed tomography for detection of coronary artery disease (PB127 Multicenter Phase 2 Trial results).

@article{Wei2003ComparisonOU,
  title={Comparison of usefulness of dipyridamole stress myocardial contrast echocardiography to technetium-99m sestamibi single-photon emission computed tomography for detection of coronary artery disease (PB127 Multicenter Phase 2 Trial results).},
  author={Kevin Wei and L. M. Crouse and James D Weiss and Flordeliza S. Villanueva and Nelson B. Schiller and Tasneem Z Naqvi and Robert Siegel and Mark Monaghan and Jonathan H Goldman and Paul Aggarwal and Harvey B Feigenbaum and Anthony DeMaria},
  journal={The American journal of cardiology},
  year={2003},
  volume={91 11},
  pages={1293-8}
}
We hypothesized that assessment of hyperemic myocardial blood flow (MBF) velocity using myocardial contrast echocardiography (MCE) can detect coronary artery disease (CAD). We also postulated that only a single MCE study during stress is required for the detection of CAD in patients with normal function at rest. Patients with known or suspected CAD referred for dipyridamole stress technetium-99m sestamibi single-photon emission computed tomographic (SPECT) studies were enrolled. MCE was… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography • 2008
View 5 Excerpts
Highly Influenced

20 years of ultrasound contrast agent modeling

IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control • 2013
View 1 Excerpt

Similar Papers

Loading similar papers…